Ibrutinib Combination Therapy in Transplant Ineligible Individuals With Newly Diagnosed Primary CNS Lymphoma
Canadian Cancer Trials Group
Canadian Cancer Trials Group
University of Michigan Rogel Cancer Center
University of Cologne
University of Miami
City of Hope Medical Center